Sunshine Biopharma, Inc.

8-K Other events Aug 3, 2026 8-K Entered a material agreement Jul 20, 2026 8-K Entered a material agreement Jul 10, 2026 8-K Shareholder vote results May 29, 2026 8-K Entered a material agreement; Other events May 19, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Apr 3, 2026 8-K Other events Mar 9, 2026 8-K Shareholder vote results Feb 20, 2026 8-K Director or officer change Feb 5, 2026 8-K Shareholder vote results Dec 12, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Changed accountants Sep 30, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) May 19, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement; Other events Apr 3, 2025 8-K Results of operations (earnings release) Apr 2, 2025 10-K Fiscal year ended 2024-12-31 Apr 1, 2025 8-K Director or officer change Jan 15, 2025 8-K Shareholder vote results Dec 10, 2024 8-K Results of operations (earnings release) Nov 7, 2024 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Director or officer change Oct 23, 2024 8-K Other events Sep 10, 2024 10-Q/A Quarter ended 2024-06-30 Aug 20, 2024 8-K Results of operations (earnings release) Aug 19, 2024 10-Q Quarter ended 2024-06-30 Aug 16, 2024 8-K Amended charter or bylaws Aug 12, 2024 8-K Shareholder vote results Jul 2, 2024 8-K Other events Jul 1, 2024 8-K Other events Jun 11, 2024 8-K Delisting notice or listing-rule failure Jun 7, 2024 8-K Results of operations (earnings release) May 22, 2024 10-Q Quarter ended 2024-03-31 May 20, 2024 8-K Changed accountants May 8, 2024 8-K Changed accountants May 6, 2024 8-K Amended charter or bylaws Apr 23, 2024 8-K Results of operations (earnings release) Apr 1, 2024